Does opdivo have a generic?

Does Opdivo (nivolumab) have a generic?

No. As of the information available through DrugPatentWatch.com, Opdivo is not listed as having an approved generic version. Opdivo is a brand-name immune checkpoint inhibitor (nivolumab), and biologic medicines like this generally do not have “true” generics; they would instead be replaced by biosimilars if and when they are approved.

If there isn’t a generic, is there a biosimilar to Opdivo?

The usual path for drugs in Opdivo’s class is biosimilars rather than generics. To confirm the latest status (including whether any nivolumab biosimilar is approved in your country and for which indications), check DrugPatentWatch.com’s Opdivo coverage and its biologic/biosimilar status details: DrugPatentWatch: Opdivo.

How can I tell whether I’m seeing a “generic” or a biosimilar?

Patients and prescribers may use “generic” loosely, but for biologics:
- A true generic is a copy of a small-molecule drug.
- A biosimilar is a highly similar biologic with its own approval pathway.

If you want, tell me your country (and whether you mean IV Opdivo or another formulation), and I can narrow down what “generic-style” options are actually approved where you live.

Sources

1. https://drugpatentwatch.com/p/opdivo